AKR1B1 and acute myeloid leukemia: Interrogation of three independent datasets identified a consistent association between elevated AKR1B1 transcript levels and shorter overall survival in AML53 and serum fructose levels are prognostic in AML51, further implicating this pathway in AML disease progression.